Genomic Classifier for Usual Interstitial Pneumonia Predicts Progression in Fibrotic Lung Disease Across a Range of Clinical Diagnoses

被引：0
|
作者：
Lancaster, L. H. [1 ]
Ryerson, C. J. [2 ]
Johnson, M. [3 ]
Huang, J. [3 ]
Burbanks-Ivey, J. [3 ]
Morrie, E. [3 ]
Lofaro, L. [3 ]
Bulman, W. [3 ]
Kennedy, G. [3 ]
Wells, A. U. [4 ]
Raghu, G.
Scholand, M. [5 ]
机构：
[1] Vanderbilt Univ, Pulm & Crit Care Med, Med Ctr, Nashville, TN USA
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[3] Veracyte Inc, San Francisco, CA USA
[4] Royal Brompton Hosp, Resp, London, England
[5] Univ Utah, Salt Lake City, UT USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2583
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features
    Cooper, Wendy A.
    Mahar, Annabelle
    Myers, Jeffrey L.
    Grainge, Christopher
    Corte, Tamera J.
    Williamson, Jonathan P.
    Vallely, Michael P.
    Lai, Simon
    Mulyadi, Ellie
    Torzillo, Paul J.
    Phillips, Martin J.
    Lau, Edmund M. T.
    Raghu, Ganesh
    Troy, Lauren K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1306 - 1313
  • [22] To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease
    Behr, Juergen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (09) : 949 - 951
  • [23] Progression and Prognostic Significance of Hypoxaemia in Fibrotic Interstitial Lung Disease
    Khor, Y. H.
    Goh, N.
    Glaspole, I.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] PROGRESSION AND PROGNOSTIC SIGNIFICANCE OF HYPOXAEMIA IN FIBROTIC INTERSTITIAL LUNG DISEASE
    Khor, Y.
    Goh, N.
    Glaspole, I
    Ryerson, C.
    RESPIROLOGY, 2020, 25 : 196 - 196
  • [25] Factors associated with rapid progression in fibrotic interstitial lung disease
    Chen, Xianqiu
    Ji, Qiuliang
    Yao, Qian
    Zhou, Ying
    HELIYON, 2023, 9 (12)
  • [26] The burden of Progressive Fibrotic Interstitial lung disease across the UK
    Simpson, Thomas
    Barratt, Shaney L.
    Beirne, Paul
    Chaudhuri, Nazia
    Crawshaw, Anjali
    Crowley, Louise E.
    Fletcher, Sophie
    Gibbons, Michael A.
    Hallchurch, Philippa
    Horgan, Laura
    Jakaityte, Ieva
    Lewis, Thomas
    McLellan, Tom
    Myall, Katherine J.
    Miller, Ryan
    Smith, David J. F.
    Stanel, Stefan
    Thillai, Muhunthan
    Thompson, Fiona
    Wallis, Timothy
    Wu, Zhe
    Molyneaux, Philip L.
    West, Alex G.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (01)
  • [27] Envisia Genomic Classifier Helps Improve Multidisciplinary Diagnoses of Complex Interstitial Lung Diseases
    Lancaster, L. H.
    Lynch, D. A.
    Colby, T. V.
    Lofaro, L.
    Pankratz, D.
    Walsh, S.
    Huang, J.
    Burbanks-Ivey, J.
    Bhorade, S.
    Kennedy, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
    Case, Amy Hajari
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] Enabling an interstitial lung disease genomic classifier on an automated platform
    Jiang, Huimin
    Schaper, Carl
    Qu, Jianghan
    Davis, Nicole
    Fedorowicz, Grazyna
    Naranja, Mark
    Lee, Kyongryun
    Storhoff, James
    Pankratz, Dan
    Sopory, Ambika
    Bhorade, Sangeeta
    Huang, Jing
    Walsh, Sean
    Kennedy, Giulia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] The Impact of Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
    Barrera, D. Espinoza
    Alanis, R. Villalobos
    Becnel, D.
    Abdelghani, R.
    Kheir, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345